Aarti Pharmalabs Limited has informed the Exchange about change in Management
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has appointed Dr. Rakeshwar Bandichhor as its Chief Scientific Officer – R&D and Senior Management Personnel, effective January 1, 2026. The appointment was approved by the Board based on the recommendation of the Nomination and Remuneration Committee. Dr. Bandichhor brings 25 years of experience in API-R&D and Process Chemistry and was previously with Dr. Reddy's Laboratories. He holds a Ph.D. in Chemistry and has completed postdoctoral trainings at universities in Germany and the USA.
Bringing in a seasoned R&D leader from a top Indian pharma company signals a push to strengthen the company's research pipeline and API development capabilities, which is positive for long-term growth, though it is a routine senior hire with no immediate material impact on the stock.